AROA BIOSURGERY LIMITED - Announcements

Market Cap $182.4M Add to my watchlist

Healthcare Biotechnology

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures,... Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.More

Announcements

Filter Results

All Price Sensitive Only

ARX	Becoming a substantial holder		01/05/24	232.02KB	Share
ARX	Investor Presentation		30/04/24	1.12MB	Share
ARX	March 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/24	384.71KB	Share
ARX	Notification of Quarterly Results Webinar - Correction		23/04/24	126.13KB	Share
ARX	Notification of Quarterly Results Webinar		23/04/24	88.69KB	Share
ARX	Notification of cessation of securities - ARX		08/04/24	14.12KB	Share
ARX	Final Director's Interest Notice - SE		04/04/24	150.17KB	Share
ARX	Change of Director's Interest Notice - SE		28/03/24	159.6KB	Share
ARX	Application for quotation of securities - ARX		28/03/24	17.9KB	Share
ARX	Section 708A Notice		28/03/24	133.49KB	Share
ARX	Initial Director's Interest Notice - DH		22/03/24	151.79KB	Share
ARX	Intuitive's Darla Hutton joins Board, Steven Engle retires		22/03/24	101.45KB	Share
ARX	Change of Director's Interest Notice - PM		23/02/24	359.52KB	Share
ARX	Change in substantial holding		20/02/24	245.5KB	Share
ARX	Notification of cessation of securities - ARX		14/02/24	14.05KB	Share
ARX	Application for quotation of securities - ARX		14/02/24	17.69KB	Share
ARX	Section 708A Notice		14/02/24	249.28KB	Share
ARX	Investor Presentation		30/01/24	965.25KB	Share
ARX	December 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/01/24	406.27KB	Share
ARX	Enivo Clinical Pilot Study		25/01/24	130.76KB	Share
ARX	Notification of Quarterly Results Webinar		23/01/24	88.86KB	Share
ARX	Notification of cessation of securities - ARX		12/01/24	28.43KB	Share
ARX	Aroa Half Year Results Presentation	PRICE SENSITIVE	28/11/23	2.12MB	Share
ARX	Aroa Biosurgery Half Yearly Results H1 FY24	PRICE SENSITIVE	28/11/23	219.19KB	Share
ARX	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/11/23	819.98KB	Share
ARX	Notification of Half Year Results Webinar		22/11/23	183.8KB	Share
ARX	AROA Investor Event		21/11/23	196.23KB	Share
ARX	Bell Potter Healthcare Conference Presentation		14/11/23	1.8MB	Share
ARX	Investor Presentation		31/10/23	1.53MB	Share
ARX	September 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/23	330.6KB	Share
ARX	Notification regarding unquoted securities - ARX		27/10/23	45.39KB	Share
ARX	Notification of Quarterly Results Webinar		24/10/23	106.1KB	Share
ARX	Study shows positive outcomes for Myriad in traumatic wounds		03/10/23	312.25KB	Share
ARX	Change of Director's Interest Notice - JM		07/09/23	365.21KB	Share
ARX	Application for quotation of securities - ARX		07/09/23	27.06KB	Share
ARX	Section 708A Notice		07/09/23	253.9KB	Share
ARX	Notification of cessation of securities - ARX		31/08/23	30.75KB	Share
ARX	Application for quotation of securities - ARX		31/08/23	26.85KB	Share
ARX	Section 708A Notice		31/08/23	255.22KB	Share
ARX	Change of Director's Interest Notice - CM		14/08/23	395.08KB	Share
ARX	Notification regarding unquoted securities - ARX		14/08/23	27.85KB	Share
ARX	Results of Annual General Meeting		03/08/23	309.12KB	Share
ARX	CEO Presentation - AGM		03/08/23	2.85MB	Share
ARX	Chairman's Address - AGM		03/08/23	300.58KB	Share
ARX	June 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/07/23	359.9KB	Share
ARX	Notification of Quarterly Results Webinar		24/07/23	93.38KB	Share
ARX	Notification of cessation of securities - ARX		14/07/23	26.71KB	Share
ARX	Notice of Annual General Meeting/Proxy Form		10/07/23	913.23KB	Share
ARX	Appendix 4G and Corporate Governance Statement		30/06/23	632.86KB	Share
ARX	Annual Report to Shareholders		30/06/23	11.3MB	Share
ARX	Notice of AGM Date and Director Nomination Closing Date		07/06/23	228.42KB	Share
ARX	Investor Presentation		01/06/23	4.96MB	Share
ARX	FY23 Full Year Results Presentation	PRICE SENSITIVE	31/05/23	1.65MB	Share
ARX	FY23 Appendix 4E and Full Year Results	PRICE SENSITIVE	31/05/23	2.66MB	Share
ARX	Notification of Full Year Results Webinar		24/05/23	97.85KB	Share
ARX	Investor Presentation		27/04/23	1.27MB	Share
ARX	March 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	27/04/23	376.56KB	Share
ARX	Notification of Quarterly Results Webinar		20/04/23	98.16KB	Share
ARX	Notification regarding unquoted securities - ARX		12/04/23	27.48KB	Share
ARX	AROA secures first FDA clearance for ENIVO system	PRICE SENSITIVE	12/04/23	98.64KB	Share
ARX	Release of Shares from Voluntary Escrow		04/04/23	202.62KB	Share
ARX	Change of Director's Interest Notice - SE		31/03/23	201.33KB	Share
ARX	Change of Director's Interest Notice - JP		31/03/23	201.35KB	Share
ARX	Change of Director's Interest Notice - JM		31/03/23	201.48KB	Share
ARX	Change of Director's Interest Notice - BW		31/03/23	203.74KB	Share
ARX	Change of Director's Interest Notice - PM		31/03/23	203.68KB	Share
ARX	Change of Director's Interest Notice - JD		31/03/23	397.35KB	Share
ARX	Notification regarding unquoted securities - ARX		31/03/23	43.35KB	Share
ARX	Aroa awarded agreement with Premier Inc		06/03/23	95.47KB	Share
ARX	Application for quotation of securities - ARX		03/02/23	28KB	Share
ARX	Section 708A Notice		03/02/23	336.13KB	Share
ARX	Investor Presentation		31/01/23	1.52MB	Share
ARX	December 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/23	359.38KB	Share
ARX	Notification of Quarterly Results Webinar		24/01/23	166.58KB	Share
ARX	Notification of cessation of securities - ARX		12/01/23	21.71KB	Share
ARX	Notification of cessation of securities - ARX		11/01/23	21.81KB	Share
ARX	Notification regarding unquoted securities - ARX		05/01/23	25.69KB	Share
ARX	Change of Director's Interest Notice - JD		16/12/22	313.33KB	Share
ARX	Notification regarding unquoted securities - ARX		16/12/22	29.07KB	Share
ARX	Section 708A Notice		16/12/22	255.27KB	Share
ARX	Application for quotation of securities - ARX		16/12/22	25.53KB	Share
ARX	Notification regarding unquoted securities - ARX		12/12/22	28.54KB	Share
ARX	Aroa Half Year Results Presentation		29/11/22	1.75MB	Share
ARX	Aroa Biosurgery Half Yearly Results H1 FY23	PRICE SENSITIVE	29/11/22	208.8KB	Share
ARX	Appendix 4D and Half Year Report	PRICE SENSITIVE	29/11/22	931.61KB	Share
ARX	Notification regarding unquoted securities - ARX		28/11/22	34.44KB	Share
ARX	Appendix 3G		28/11/22	219.5KB	Share
ARX	Notification of Half Year Results Webinar		23/11/22	167.44KB	Share
ARX	Initial Director's Interest Notice - CM		08/11/22	188.38KB	Share
ARX	Change of Registry Address		31/10/22	77.61KB	Share
ARX	Becoming a substantial holder		26/10/22	184.14KB	Share
ARX	Investor Presentation		25/10/22	14.24MB	Share
ARX	September 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	25/10/22	1009.97KB	Share
ARX	Notification of Quarterly Webinar		19/10/22	154.63KB	Share
ARX	Pre-Clinical Study of Enivo Shows Potential		18/10/22	360.37KB	Share
ARX	Notification of cessation of securities - ARX		12/10/22	24.36KB	Share
ARX	Dr Catherine Mohr to join Aroa Board		13/09/22	257.45KB	Share
ARX	Change of Director's Interest Notice - JD		02/09/22	115.03KB	Share
ARX	Results of Annual General Meeting		10/08/22	253.6KB	Share
ARX	CEO Presentation - AGM		10/08/22	1.64MB	Share

ARX Becoming a substantial holder
01/05/24		232.02KB	Share
ARX Investor Presentation
30/04/24		1.12MB	Share
ARX March 2024 Quarterly Report and Appendix 4C
30/04/24	PRICE SENSITIVE	384.71KB	Share
ARX Notification of Quarterly Results Webinar - Correction
23/04/24		126.13KB	Share
ARX Notification of Quarterly Results Webinar
23/04/24		88.69KB	Share
ARX Notification of cessation of securities - ARX
08/04/24		14.12KB	Share
ARX Final Director's Interest Notice - SE
04/04/24		150.17KB	Share
ARX Change of Director's Interest Notice - SE
28/03/24		159.6KB	Share
ARX Application for quotation of securities - ARX
28/03/24		17.9KB	Share
ARX Section 708A Notice
28/03/24		133.49KB	Share
ARX Initial Director's Interest Notice - DH
22/03/24		151.79KB	Share
ARX Intuitive's Darla Hutton joins Board, Steven Engle retires
22/03/24		101.45KB	Share
ARX Change of Director's Interest Notice - PM
23/02/24		359.52KB	Share
ARX Change in substantial holding
20/02/24		245.5KB	Share
ARX Notification of cessation of securities - ARX
14/02/24		14.05KB	Share
ARX Application for quotation of securities - ARX
14/02/24		17.69KB	Share
ARX Section 708A Notice
14/02/24		249.28KB	Share
ARX Investor Presentation
30/01/24		965.25KB	Share
ARX December 2023 Quarterly Report and Appendix 4C
30/01/24	PRICE SENSITIVE	406.27KB	Share
ARX Enivo Clinical Pilot Study
25/01/24		130.76KB	Share
ARX Notification of Quarterly Results Webinar
23/01/24		88.86KB	Share
ARX Notification of cessation of securities - ARX
12/01/24		28.43KB	Share
ARX Aroa Half Year Results Presentation
28/11/23	PRICE SENSITIVE	2.12MB	Share
ARX Aroa Biosurgery Half Yearly Results H1 FY24
28/11/23	PRICE SENSITIVE	219.19KB	Share
ARX Appendix 4D and Half Year Report
28/11/23	PRICE SENSITIVE	819.98KB	Share
ARX Notification of Half Year Results Webinar
22/11/23		183.8KB	Share
ARX AROA Investor Event
21/11/23		196.23KB	Share
ARX Bell Potter Healthcare Conference Presentation
14/11/23		1.8MB	Share
ARX Investor Presentation
31/10/23		1.53MB	Share
ARX September 2023 Quarterly Report and Appendix 4C
31/10/23	PRICE SENSITIVE	330.6KB	Share
ARX Notification regarding unquoted securities - ARX
27/10/23		45.39KB	Share
ARX Notification of Quarterly Results Webinar
24/10/23		106.1KB	Share
ARX Study shows positive outcomes for Myriad in traumatic wounds
03/10/23		312.25KB	Share
ARX Change of Director's Interest Notice - JM
07/09/23		365.21KB	Share
ARX Application for quotation of securities - ARX
07/09/23		27.06KB	Share
ARX Section 708A Notice
07/09/23		253.9KB	Share
ARX Notification of cessation of securities - ARX
31/08/23		30.75KB	Share
ARX Application for quotation of securities - ARX
31/08/23		26.85KB	Share
ARX Section 708A Notice
31/08/23		255.22KB	Share
ARX Change of Director's Interest Notice - CM
14/08/23		395.08KB	Share
ARX Notification regarding unquoted securities - ARX
14/08/23		27.85KB	Share
ARX Results of Annual General Meeting
03/08/23		309.12KB	Share
ARX CEO Presentation - AGM
03/08/23		2.85MB	Share
ARX Chairman's Address - AGM
03/08/23		300.58KB	Share
ARX June 2023 Quarterly Report and Appendix 4C
31/07/23	PRICE SENSITIVE	359.9KB	Share
ARX Notification of Quarterly Results Webinar
24/07/23		93.38KB	Share
ARX Notification of cessation of securities - ARX
14/07/23		26.71KB	Share
ARX Notice of Annual General Meeting/Proxy Form
10/07/23		913.23KB	Share
ARX Appendix 4G and Corporate Governance Statement
30/06/23		632.86KB	Share
ARX Annual Report to Shareholders
30/06/23		11.3MB	Share
ARX Notice of AGM Date and Director Nomination Closing Date
07/06/23		228.42KB	Share
ARX Investor Presentation
01/06/23		4.96MB	Share
ARX FY23 Full Year Results Presentation
31/05/23	PRICE SENSITIVE	1.65MB	Share
ARX FY23 Appendix 4E and Full Year Results
31/05/23	PRICE SENSITIVE	2.66MB	Share
ARX Notification of Full Year Results Webinar
24/05/23		97.85KB	Share
ARX Investor Presentation
27/04/23		1.27MB	Share
ARX March 2023 Quarterly Report and Appendix 4C
27/04/23	PRICE SENSITIVE	376.56KB	Share
ARX Notification of Quarterly Results Webinar
20/04/23		98.16KB	Share
ARX Notification regarding unquoted securities - ARX
12/04/23		27.48KB	Share
ARX AROA secures first FDA clearance for ENIVO system
12/04/23	PRICE SENSITIVE	98.64KB	Share
ARX Release of Shares from Voluntary Escrow
04/04/23		202.62KB	Share
ARX Change of Director's Interest Notice - SE
31/03/23		201.33KB	Share
ARX Change of Director's Interest Notice - JP
31/03/23		201.35KB	Share
ARX Change of Director's Interest Notice - JM
31/03/23		201.48KB	Share
ARX Change of Director's Interest Notice - BW
31/03/23		203.74KB	Share
ARX Change of Director's Interest Notice - PM
31/03/23		203.68KB	Share
ARX Change of Director's Interest Notice - JD
31/03/23		397.35KB	Share
ARX Notification regarding unquoted securities - ARX
31/03/23		43.35KB	Share
ARX Aroa awarded agreement with Premier Inc
06/03/23		95.47KB	Share
ARX Application for quotation of securities - ARX
03/02/23		28KB	Share
ARX Section 708A Notice
03/02/23		336.13KB	Share
ARX Investor Presentation
31/01/23		1.52MB	Share
ARX December 2022 Quarterly Report and Appendix 4C
31/01/23	PRICE SENSITIVE	359.38KB	Share
ARX Notification of Quarterly Results Webinar
24/01/23		166.58KB	Share
ARX Notification of cessation of securities - ARX
12/01/23		21.71KB	Share
ARX Notification of cessation of securities - ARX
11/01/23		21.81KB	Share
ARX Notification regarding unquoted securities - ARX
05/01/23		25.69KB	Share
ARX Change of Director's Interest Notice - JD
16/12/22		313.33KB	Share
ARX Notification regarding unquoted securities - ARX
16/12/22		29.07KB	Share
ARX Section 708A Notice
16/12/22		255.27KB	Share
ARX Application for quotation of securities - ARX
16/12/22		25.53KB	Share
ARX Notification regarding unquoted securities - ARX
12/12/22		28.54KB	Share
ARX Aroa Half Year Results Presentation
29/11/22		1.75MB	Share
ARX Aroa Biosurgery Half Yearly Results H1 FY23
29/11/22	PRICE SENSITIVE	208.8KB	Share
ARX Appendix 4D and Half Year Report
29/11/22	PRICE SENSITIVE	931.61KB	Share
ARX Notification regarding unquoted securities - ARX
28/11/22		34.44KB	Share
ARX Appendix 3G
28/11/22		219.5KB	Share
ARX Notification of Half Year Results Webinar
23/11/22		167.44KB	Share
ARX Initial Director's Interest Notice - CM
08/11/22		188.38KB	Share
ARX Change of Registry Address
31/10/22		77.61KB	Share
ARX Becoming a substantial holder
26/10/22		184.14KB	Share
ARX Investor Presentation
25/10/22		14.24MB	Share
ARX September 2022 Quarterly Report and Appendix 4C
25/10/22	PRICE SENSITIVE	1009.97KB	Share
ARX Notification of Quarterly Webinar
19/10/22		154.63KB	Share
ARX Pre-Clinical Study of Enivo Shows Potential
18/10/22		360.37KB	Share
ARX Notification of cessation of securities - ARX
12/10/22		24.36KB	Share
ARX Dr Catherine Mohr to join Aroa Board
13/09/22		257.45KB	Share
ARX Change of Director's Interest Notice - JD
02/09/22		115.03KB	Share
ARX Results of Annual General Meeting
10/08/22		253.6KB	Share
ARX CEO Presentation - AGM
10/08/22		1.64MB	Share

REFRESH

1 2

(20min delay)
Last 53.0¢		Change -0.010(1.85%)		Mkt cap ! $182.4M

Open	High	Low	Value	Volume
53.0¢	53.0¢	53.0¢	$1.59K	3K

Buyers (Bids)

No.	Vol.	Price($)
4	35924	53.0¢

Sellers (Offers)

Price($)	Vol.	No.
54.5¢	11062	1

View Market Depth

No.	Vol.	Price($)
4	33819	0.530
3	21787	0.525
1	19000	0.520
4	98232	0.510
5	42410	0.505

Price($)	Vol.	No.
0.545	11062	1
0.550	21408	2
0.555	1904	1
0.565	4301	2
0.575	278	1

Last trade - 10.00am 07/05/2024 (20 minute delay)


Last 53.5¢		Change -0.010 ( 1.87 %)
Open	High	Low	Volume
53.5¢	53.5¢	53.5¢	1281
Last updated 10.40am 07/05/2024 ?

ARX (ASX) Chart

AROA BIOSURGERY LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories